Symplur COVID-19 Dashboards
Request Access We are continually reviewing requests. You’ll hear from us shortly. Symplur COVID-19 Dashboard What will you get access to? Over 100 million COVID-19 and SARS-CoV-2 related tweets are shared every…
Request Access We are continually reviewing requests. You’ll hear from us shortly. Symplur COVID-19 Dashboard What will you get access to? Over 100 million COVID-19 and SARS-CoV-2 related tweets are shared every…
This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.
The development and regulatory approval of vemurafenib and dabrafenib for metastatic melanoma patients with activating BRAF mutations has demonstrated that personalized targeted therapy strategies can…
Ramaswamy Govindan Washington University School of Medicine, St. Louis, MO Ramaswamy Govindan, Katie Navo, Minxuan Huang, Calvin Y. Chao, Sumithra Sankararaman, KELLY L BOLTON, Yin…
Program: Oral and Poster Abstracts Session: 731. Clinical Autologous Transplantation: Results: Poster I Hematology Disease Topics & Pathways: Adult, Non-Biological, Therapies, Study Population, Clinically relevant…
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Nature – This study develops a method for spatially resolving multipotent haematopoiesis, erythropoiesis and lymphopoiesis in mice and uncovers heterogeneous haematopoietic stress responses in…
Nature – This study develops a method for spatially resolving multipotent haematopoiesis, erythropoiesis and lymphopoiesis in mice and uncovers heterogeneous haematopoietic stress responses in…
Purpose: This study sought to describe the changes in immune response to a third dose of either Pfizer’s or Moderna’s COVID-19 mRNA vaccine (3V) among…
e19513 Background: Patients (Pts) with hematologic malignancies (HM) are at greater risk of severe morbidity and mortality caused by COVID19 and show a lower response…
A tenth of patients die within 60 days of diagnosis of MM. Infection and renal failure are the main direct causes of early mortality, which…